Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

 Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

Shots:

  • The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger, Ginkgo is eligible to receive ~1.63B in gross proceeds including $775M from a PIPE and ~$858M from the Soaring Eagle trust account
  • Soaring Eagle will now change its name to Ginkgo Bioworks and the combined company’s shares of Class A common stock will trade on NYSE under the ticker symbols “DNA and DNA.WS” respectively
  • Ginkgo has built a platform for cell programming that can be used by companies across multiples industries to develop products such as food ingredients, fragrances, cosmetics & medicines respectively

Click here to read full press release/ article | Ref: Businesswire | Image: PR Newswire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post